|
After an extensive national search led by Korn Ferry, Tower Cancer Research Foundation's Board of Directors is pleased to announce that Christopher Clinton Conway has joined the Foundation as its new Chief Executive Officer. Christopher brings a wealth of philanthropic and executive leadership experience and a passion for changing the course of cancer.
"The Board of Directors is thrilled that Christopher will join us to lead the Foundation's strategic agenda to expand resources for innovative cancer research and survivorship support. Christopher is the right leader at the right time to take TCRF to the next level. He embodies the right combination of experience — a passion for finding better treatments for those affected by cancer alongside a firm grasp of what is required to progress an organization to meaningful impact.
"In selecting Christopher, we have found a strong leader who is energetic, intelligent, and knowledgeable about oncology research and nonprofit fundraising, marketing, and management. Christopher has invaluable insights to help the Foundation become the leading organization supporting cancer research and patient support in Southern California," said Dr. Solomon I. Hamburg, MD-PhD, President of the Board of Directors.
| 
